While Valeant Pharmaceuticals faced numerous legal and financial issues in 2016, the drugmaker paid its CEO Joseph Papa $63 million last year, reports CNN Money. Valeant filed documents with ...

Valeant Pharmaceutical recently completed its rebrand, becoming Bausch Health to reflect the success of its flagship division, Bausch and Lomb. Bausch Health CEO Joseph Papa spoke to the Rochester ...

(Reuters) -Emergent BioSolutions said on Wednesday it has named former Bausch + Lomb CEO Joseph Papa to the top job as the company, which makes the opioid overdose reversal drug Narcan, aims to return ...

(RTTNews) - Specialty biopharmaceutical company Emergent BioSolutions Inc. (EBS) announced Wednesday that its Board of Directors has appointed Joseph Papa as president and CEO, effective February 21, ...

CEO Joseph Papa stated that "we had another great quarter and are on track to exceed our initial 2025 revenue and adjusted EBITDA guidance." He highlighted securing 11 contract modifications and ...

Laval, Quebec, Canada-based Valeant Pharmaceuticals has named Joseph Papa CEO after he resigned from Allegan, Mich.-based Perrigo, according to Reuters. In March, Valeant announced J. Michael Pearson, ...

Papa will lead Emergent into a new era of focusing on protecting public health, returning to growth and paying down the company’s debt “Whether it’s increasing access to NARCAN ® Nasal Spray, which is ...